The bacterium Clostridioides difficile is named “difficult” for a reason. Originally it was hard to grow in the lab, and now ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

Now imagine a case that rages on and on -- or comes back again and again. This is the reality for nearly 500,000 Americans each year who have the bacterial infection known as Clostridioides difficile, ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The superbug Clostridioides difficile, or C. diff, can cause dangerous gut infections. There are limited options for treating ...

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Research has shown bleaches used in hospital are not effective against C. diff One of the main types of disinfectant used to clean hospital scrubs and surfaces does not work against a common ...

The Royal Liverpool Hospital has missed its targets on C.diff infections for eight consecutive months Sub-standard cleaning in hospitals may be linked to rising cases of the bacterial infection C.